Hepatitis C.
el-Sayed
A M
AM
Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Sharara
A I
AI
D000998:Antiviral Agents / Q000627:therapeutic use; D016174:Hepacivirus / Q000235:genetics / Q000472:pathogenicity*; D006526:Hepatitis C / Q000453:epidemiology / Q000628:therapy / Q000635:transmission; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007861:Lebanon / Q000453:epidemiology; D016031:Liver Transplantation; D012254:Ribavirin / Q000627:therapeutic use; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D014761:Viral Hepatitis Vaccines; D012254:Ribavirin; D007372:Interferons